RLYB (Rallybio) Short-Term Debt to Capital

Corporate company logo of Rallybio Corp (RLYB)

The price chart for Rallybio Corporation (RLYB) demonstrates the 0.00 indicator. Rallybio Corporation is implementing software robots and automated screening to accelerate the analysis of medical data. The business relies on partnerships with global laboratories to create antibodies for fetal protection. US-based production facilities are focused on innovative therapies for severe neonatal blood pathologies, which have been validated by successful tests.

Ratio of Short-Term Indebtedness to Capital: rallybio.com (RLYB) for 07/04/2022 - 11/01/2026

Analytical breakdowns for Rallybio Corporation

- stock quotes and analyst forecast:
Stock Price Rallybio Corporation|RLYB - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Rallybio Corp|RLYB - Enterprise Value
- book capitalization information:
Net Assets per Single Share Rallybio|RLYB - Accounting Value of Company|Market Value to Book Value Ratio rallybio.com|RLYB - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Rallybio Corporation|RLYB - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Rallybio Corporation|RLYB - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Rallybio Corp|RLYB - Long-Term Debt|Company Current Liabilities Rallybio|Quick Ratio rallybio.com
- company profitability and valuation multiples indicators:
RLYB - Final Profit
Fundamental valuation:RLYB Rallybio
Brand item of rallybio.com

Complex FDA clinical trials for Rallybio Corporation (RLYB) drugs require significant operating expenses, making the company sensitive to the cost of borrowed capital. This indicator measures the share of short-term liabilities within the equity structure, allowing for an assessment of liquidity risk and dependence on external financing through the ratio of current loans to equity.

Competitors of Rallybio Corporation (RLYB)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|Ratio of Short-Term Indebtedness to Capital EXOZ|Oramed Pharma - Short-Term Debt to Capital|ENTX - Short-Term Debt to Capital|MindWalk Holdings (HYFT) - Short-Term Debt to Equity|ABVC (abvcpharma.com) - Short-Term Debt to Equity|Short-Term Debt to Equity Cumberland Pharmaceuticals Inc.|Short-Term Debt to Equity QNTM|Short-Term Debt to Equity Ratio FGEN (FibroGen Corp)|TELO - Current Liabilities to Capital|Short-Term Debt to Capital RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. - Short-Term Debt to Equity|Lexaria - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Pulmatrix Inc PULM|ftzy.com.cn (PTHL) - Short-Term Debt to Equity|Current Liabilities to Capital Aptorum Group (APM)|Short-Term Debt to Equity Ratio LYRA|IBO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TNFA|Short-Term Debt to Equity Ratio cbdmd.com YCBD|Short-Term Debt to Equity PainReform Limited PRFX|Altamira Therapeutics Ltd (CYTO) - Current Liabilities to Capital|LIPO - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital OPTN (optinose.com)|Pieris Pharmaceuticals, Inc. (PIRS) - Short-Term Debt to Equity|Current Liabilities to Equity PROC (Procaps Group)|Short-Term Debt to Equity Petros|Current Liabilities to Capital Qilian International Corp QLI|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP (tffpharma.com) - Ratio of Short-Term Indebtedness to Capital